KALA BIO, Inc.
Datakwaliteit: 83%
KALA
Nasdaq
Manufacturing
Chemicals
€ 0,18
▲
€ 0,00
(2,64%)
Marktkapitalisatie: 166,32 M
Prijs
€ 0,18
Marktkapitalisatie
166,32 M
Dagbereik
€ 0,17 — € 0,19
52-Weeksbereik
€ 0,15 — € 20,60
Volume
1.454.736
Openen € 0,18
50D / 200D Gem.
€ 0,35
47,89% below
50D / 200D Gem.
€ 3,77
95,16% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -32,03 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-485,93%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,75
Interest Coverage-8,48
Waardering
PE (TTM)
-4,64
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4,6 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -35,84 M |
| ROE | N/A | ROA | -117,37% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -32,03 M |
| ROIC | -485,93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,75 |
| Interest Coverage | -8,48 | Asset Turnover | N/A |
| Working Capital | -8,30 M | Tangible Book Value | -8,67 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4,64 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -19,26% | ||
| Market Cap | 166,32 M | Enterprise Value | 172,17 M |
| Per Share | |||
| EPS (Diluted TTM) | -5,64 | Revenue / Share | N/A |
| FCF / Share | -0,04 | OCF / Share | -0,04 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 89,38% |
| SBC-Adj. FCF | -40,66 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -38,51 M | -42,20 M | -44,82 M | -142,61 M | -104,33 M |
| EPS (Diluted) | -10,15 | -17,35 | -29,48 | -2,19 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -40,98 M | -39,66 M | -81,71 M | -130,25 M | -96,23 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | 18,35 M |
| SG&A Expenses | — | 20,57 M | 65,04 M | 105,06 M | 81,07 M |
| D&A | 259.000,0 | 303.000,0 | 537.000,0 | 975.000,0 | 912.000,0 |
| Interest Expense | 5,78 M | 5,81 M | 7,27 M | 8,38 M | 8,59 M |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 55,48 M | 55,95 M | 86,82 M | 139,43 M | 221,61 M |
| Total Liabilities | 43,15 M | 48,45 M | 67,85 M | 122,62 M | 121,61 M |
| Shareholders' Equity | 12,33 M | 7,50 M | 18,97 M | 16,80 M | 100,00 M |
| Total Debt | 20,10 M | 34,19 M | 43,30 M | 80,00 M | 75,00 M |
| Cash & Equivalents | 51,18 M | 50,90 M | 70,50 M | 92,14 M | 77,26 M |
| Current Assets | 52,80 M | 52,87 M | 85,94 M | 124,37 M | 171,38 M |
| Current Liabilities | 16,96 M | 8,35 M | 25,69 M | 37,42 M | 22,23 M |
{"event":"ticker_viewed","properties":{"ticker":"KALA","listing_kind":"stock","pathname":"/stocks/kala","exchange":"Nasdaq","country":"US"}}